Dimensional Fund Advisors
NMRA icon

Dimensional Fund Advisors’s Neumora Therapeutics NMRA Stock Holding History

Dimensional Fund Advisors’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$692K Buy
354,850
+247,600
+231% +$642K ﹤0.01% 2902
2025
Q4 		$192K Buy
107,250
+2,267
+2% +$4.96K ﹤0.01% 3095
2025
Q3 		$191K Hold
104,983
– – ﹤0.01% 3125
2025
Q2 		$77K Sell
104,983
-83,435
-44% -$63.2K ﹤0.01% 3206
2025
Q1 		$188K Buy
+188,418
New +$323K ﹤0.01% 3139

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

Dimensional Fund Advisors's NMRA Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Neumora Therapeutics (NMRA) stake by 231% in Q1 2026, buying an estimated $642K and bringing the position to 354,850 shares worth $692K. The position accounts for ﹤0.01% of the portfolio, ranked #2902.

Dimensional Fund Advisors first reported a position in NMRA in Q1 2025 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

  • Dimensional Fund Advisors held 354,850 shares of Neumora Therapeutics worth $692K as of Q1 2026.
  • Dimensional Fund Advisors bought 247,600 Neumora Therapeutics shares in Q1 2026, an estimated $642K.
  • Neumora Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2902 holding.
  • Dimensional Fund Advisors first reported a position in Neumora Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.